We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Diagnostic Technology Performs Rapid Biofluid Analysis Using Single Droplet

By LabMedica International staff writers
Posted on 04 Dec 2025

Diagnosing disease typically requires milliliters of blood drawn at clinics, depending on needles, laboratory infrastructure, and trained personnel. More...

This process is often painful, resource-intensive, and inaccessible in many regions. Existing workflows overlook the rich diagnostic information embedded in the physical changes that biofluids undergo as they dry. Now, researchers have developed an automated imaging and machine-learning system that analyzes how tiny droplets of blood and other fluids dry to distinguish normal from abnormal samples.

The automated system, developed by researchers at the University of Tokyo (Tokyo, Japan), reduces reliance on traditional phlebotomy and expensive consumables by using microscopic imaging to observe biofluid droplets drying in real time. It eliminates the need for specialized diagnostic equipment by using a simple brightfield microscope with a 4x objective lens and a digital camera.

During the drying process, droplets undergo shape changes and internal pattern evolution driven by the movement of proteins, cells, and other biomolecules. These dynamic structural changes are captured frame by frame and then interpreted by a machine-learning algorithm trained to identify disease-associated abnormalities. Because the method relies on naturally occurring drying behaviors, it can also analyze saliva and urine without additional tools.

The research team demonstrated that time-evolving droplet images provide richer diagnostic information than solely examining the final dried pattern. Their machine-learning models accurately distinguished healthy from abnormal biofluid samples across multiple conditions, including diabetes, influenza, and malaria. In validation experiments, published in Science Advances, the researchers confirmed that the real-time drying profile carries a unique signature of the fluid’s composition.

This proof-of-concept work shows how drying-based imaging can serve as a rapid, low-cost diagnostic platform suitable for global deployment, especially in low-resource settings. By relying on tiny droplets instead of venous blood draws, the method enables broader screening, improves accessibility, and reduces medical waste. The researchers envision a portable device or mobile-based workflow that could extend laboratory-grade insights to populations without access to traditional testing. Future work aims to transform the system into a practical point-of-care health-screening tool.

“Such a tool could make health monitoring faster, more affordable and more accessible, especially in communities with limited access to laboratory testing. Ultimately, our goal is to bring laboratory-level insights to the point of care, enabling early detection and preventive health care for everyone,” said Amalesh Gope, co-author of the study.

Related Link
University of Tokyo


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.